MCKENZIE W THORPE sold 11.9% of their position (11.88K shares) of XBIOTECH INC. on the open market
Open‑market sale worth $52.9K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 8/1/2018ACC: 0001209191-18-044669
-11.88K
Net shares
Net seller
$52.9K
Total sold
2
Open market trades
0B · 2S
2
Total transactions
11.88K disposed
Non-Derivative Transactions2
Common Stock
Indirect
Shares
−5.34K
Price / share
$4.41
Trade value
$23.54K
% of position
5.3%
7/30/2018
100K→94.66K
Common Stock
Indirect
Shares
−6.53K
Price / share
$4.49
Trade value
$29.32K
% of position
6.9%
7/31/2018
94.66K→88.13K
Total
Net shares
−11.88K
Net value
-$52.86K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 7/30/2018 | S · Sale | −5.34K | $4.41 | $23.54K | 5.3% | 100K | 94.66K |
| Common Stock Indirect | 7/31/2018 | S · Sale | −6.53K | $4.49 | $29.32K | 6.9% | 94.66K | 88.13K |
| Total | −11.88K | -$52.86K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)3
Common Stock
DirectShares owned3.90M
Common Stock
IndirectShares owned11.50K
Common Stock
IndirectShares owned100K
Total
3.90M direct·111.50K indirect4.01M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 3.90M | Direct |
| Common Stock | 11.50K | Indirect |
| Common Stock | 100K | Indirect |
| Total | 4.01M | 3.90M direct·111.50K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported